Cargando…

Trends in 5-, 10-, 20-, and 30-year survival rates of beta-thalassemia patients in Southern Iran, 1995-2016: A retrospective cohort study

Background: There is currently lack of knowledge about survival trend analysis of thalassemia patients. Therefore, the aim of the present study was to assess 5-, 10-, 20-, and 30-year survival of thalassemia patients over a 20-year time period. Methods: In this retrospective cohort study, we analyse...

Descripción completa

Detalles Bibliográficos
Autores principales: Hassanzadeh, Jafar, Mirahmadizadeh, Alireza, Karimi, Mehran, Veisani, Yousef, Rezaeian, Shahab
Formato: Online Artículo Texto
Lenguaje:English
Publicado: PAGEPress Publications, Pavia, Italy 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5737000/
https://www.ncbi.nlm.nih.gov/pubmed/29291192
http://dx.doi.org/10.4081/jphr.2017.1001
_version_ 1783287461089116160
author Hassanzadeh, Jafar
Mirahmadizadeh, Alireza
Karimi, Mehran
Veisani, Yousef
Rezaeian, Shahab
author_facet Hassanzadeh, Jafar
Mirahmadizadeh, Alireza
Karimi, Mehran
Veisani, Yousef
Rezaeian, Shahab
author_sort Hassanzadeh, Jafar
collection PubMed
description Background: There is currently lack of knowledge about survival trend analysis of thalassemia patients. Therefore, the aim of the present study was to assess 5-, 10-, 20-, and 30-year survival of thalassemia patients over a 20-year time period. Methods: In this retrospective cohort study, we analysed the data of 982 beta-thalassemia patients in Iran. Birth cohort and traditional cohort analyses were used to obtain the 5-, 10-, 20-, and 30-year survival rates in various time intervals between 1995 and 2016. Results: Five and 10-year survival rates remained unchanged since 1995-2016. Overall, 20- and 30-year survival rates were lower in younger birth cohorts than older ones. A declining trend was found in 20-year survival rate from 1995 to 2000 for all and also for thalassemia major patients, but was stable from 2001 to 2016. In addition, there was a declining trend in 30-year survival rate from 1995 to 2008 for all and also for thalassemia major patients, but was an increased trend from 2009 to 2016. Conclusion: Over the past two decades and in recent birth cohorts, the 20- and 30-year survival rates has declined. In other words, declining survival trends in the birth cohorts may be associated with some different causes of mortality such as exposure to the toxic effects of iron over time and the occurrence of diseaserelated mortality.
format Online
Article
Text
id pubmed-5737000
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher PAGEPress Publications, Pavia, Italy
record_format MEDLINE/PubMed
spelling pubmed-57370002017-12-29 Trends in 5-, 10-, 20-, and 30-year survival rates of beta-thalassemia patients in Southern Iran, 1995-2016: A retrospective cohort study Hassanzadeh, Jafar Mirahmadizadeh, Alireza Karimi, Mehran Veisani, Yousef Rezaeian, Shahab J Public Health Res Article Background: There is currently lack of knowledge about survival trend analysis of thalassemia patients. Therefore, the aim of the present study was to assess 5-, 10-, 20-, and 30-year survival of thalassemia patients over a 20-year time period. Methods: In this retrospective cohort study, we analysed the data of 982 beta-thalassemia patients in Iran. Birth cohort and traditional cohort analyses were used to obtain the 5-, 10-, 20-, and 30-year survival rates in various time intervals between 1995 and 2016. Results: Five and 10-year survival rates remained unchanged since 1995-2016. Overall, 20- and 30-year survival rates were lower in younger birth cohorts than older ones. A declining trend was found in 20-year survival rate from 1995 to 2000 for all and also for thalassemia major patients, but was stable from 2001 to 2016. In addition, there was a declining trend in 30-year survival rate from 1995 to 2008 for all and also for thalassemia major patients, but was an increased trend from 2009 to 2016. Conclusion: Over the past two decades and in recent birth cohorts, the 20- and 30-year survival rates has declined. In other words, declining survival trends in the birth cohorts may be associated with some different causes of mortality such as exposure to the toxic effects of iron over time and the occurrence of diseaserelated mortality. PAGEPress Publications, Pavia, Italy 2017-12-13 /pmc/articles/PMC5737000/ /pubmed/29291192 http://dx.doi.org/10.4081/jphr.2017.1001 Text en ©Copyright xxx et al., 2017 http://creativecommons.org/licenses/by-nc/4.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Article
Hassanzadeh, Jafar
Mirahmadizadeh, Alireza
Karimi, Mehran
Veisani, Yousef
Rezaeian, Shahab
Trends in 5-, 10-, 20-, and 30-year survival rates of beta-thalassemia patients in Southern Iran, 1995-2016: A retrospective cohort study
title Trends in 5-, 10-, 20-, and 30-year survival rates of beta-thalassemia patients in Southern Iran, 1995-2016: A retrospective cohort study
title_full Trends in 5-, 10-, 20-, and 30-year survival rates of beta-thalassemia patients in Southern Iran, 1995-2016: A retrospective cohort study
title_fullStr Trends in 5-, 10-, 20-, and 30-year survival rates of beta-thalassemia patients in Southern Iran, 1995-2016: A retrospective cohort study
title_full_unstemmed Trends in 5-, 10-, 20-, and 30-year survival rates of beta-thalassemia patients in Southern Iran, 1995-2016: A retrospective cohort study
title_short Trends in 5-, 10-, 20-, and 30-year survival rates of beta-thalassemia patients in Southern Iran, 1995-2016: A retrospective cohort study
title_sort trends in 5-, 10-, 20-, and 30-year survival rates of beta-thalassemia patients in southern iran, 1995-2016: a retrospective cohort study
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5737000/
https://www.ncbi.nlm.nih.gov/pubmed/29291192
http://dx.doi.org/10.4081/jphr.2017.1001
work_keys_str_mv AT hassanzadehjafar trendsin51020and30yearsurvivalratesofbetathalassemiapatientsinsoutherniran19952016aretrospectivecohortstudy
AT mirahmadizadehalireza trendsin51020and30yearsurvivalratesofbetathalassemiapatientsinsoutherniran19952016aretrospectivecohortstudy
AT karimimehran trendsin51020and30yearsurvivalratesofbetathalassemiapatientsinsoutherniran19952016aretrospectivecohortstudy
AT veisaniyousef trendsin51020and30yearsurvivalratesofbetathalassemiapatientsinsoutherniran19952016aretrospectivecohortstudy
AT rezaeianshahab trendsin51020and30yearsurvivalratesofbetathalassemiapatientsinsoutherniran19952016aretrospectivecohortstudy